Study procedure
bleeding
BLEEDING
Once consent was obtained, women were randomized either to the ENG-IMPLANT group or the DSG + ENG-IMPLANT group. In the ENG-IMPLANT group, the implant was inserted immediately. In the DSG + ENG-IMPLANT group, patients were given a 3 months’ supply of DSG to be started immediately after which insertion of ENG-IMPLANT was proposed. In both groups, patients were instructed to complete a bleeding calendar and a satisfaction questionnaire. A 3-month visit was pre-programmed for all participants, during which the bleeding calendar and the questionnaire were collected. Participants in the DSG + ENG-IMPLANT group who completed the 3 months on DSG pill had their ENG-IMPLANT inserted during this visit. All patients were seen or called over the phone after 12 months post ENG-IMPLANT insertion in both groups. Women who had their implant removed between 3 to 12 months after the insertion completed the satisfaction questionnaire at the time of removal.